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ABSTRACT  
 
Fat Associated Lymphoid Clusters (FALCs) are a recently discovered type of lymphoid 
tissue associated with visceral fat. Here we show that the distribution of FALCs is 
heterogeneous with the pericardium containing a very large number. FALCs contribute to 
the retention of B1 cells in the peritoneal cavity through high expression of CXCL13 and 
support B cell proliferation and germinal centre differentiation during peritoneal immune 
challenges. Their formation is induced by inflammation, which triggers an important 
recruitment of myeloid cells that express TNF necessary for TNFR-signaling in stromal 
cells. Finally, we demonstrate that NKT cells play a crucial role in the inducible formation 
of FALCs, placing these clusters at the centre of innate like B and T cell activation during 
serosal immune responses.  
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INTRODUCTION 
 
The peritoneal and pleural cavities constitute compartments with special characteristics to 
support rapid immune responses when the integrity of the intestine and the lungs is 
compromised/lost. A common feature of these compartments is the presence of a 
significant fraction of B1 cells that encompass diverse mouse innate-like B cell populations 
producing natural antibodies vital for the early control of infections, protecting against auto-
immunity and contributing to adaptive immunity1-7. These B1 cells recirculate between the 
peritoneal space and the omentum8, a sheet of intra-abdominal adipose tissue containing 
lymphoid structures called “milky spots”, that acts as a direct filter of the peritoneal cavity9-
12. Upon peritoneal inflammation the number and size of milky spots increases and the 
recruitment of lymphocytes and macrophages phagocytosing particles and pathogens is 
dramaticaly augmented9, 11, 12. The omentum also acts as a secondary lymphoid structure 
that promotes immunity to peritoneal antigens10, 12. 
 More recently, the existence of B cell rich clusters in adipose tissue has been 
extended to the rest of the visceral adipose tissue (VAT) in the peritoneal and pleural 
cavity13, 14. Moro and collaborators named them Fat Associated Lymphoid Clusters 
(FALCs)14. Their development was associated with the presence of Group 2 innate 
lymphoid cells  (ILC2, also known as Innate type 2 helper cells/Nuocytes/Natural helper 
cells14-17) in VAT, yet no direct evidence has shown that ILC2s induce formation of 
FALCs14. The exact composition of these clusters, their relative distribution in the different 
VAT deposits as well as their function and the mechanisms regulating their formation 
remain unknown.  
 Here we show that the distribution of lymphoid structures in adipose tissue is very 
heterogeneous, with the omentum, the pericardium and mediastinum being the tissues 
containing the largest number of FALCs. We report that the development of FALCs is 
regulated by unique cellular and molecular mechanisms that in contrast to other secondary 
lymphoid tissues do not involve lymphoid tissue inducer (LTi) cells/ILC3 and the 
Lymphotoxin Beta Receptor (LTβR) pathway18-20. Their postnatal formation was partly 
dependent on TNFR signalling and the presence of the commensal flora. The stromal cells 
of FALCs expressed high levels of CXCL13 crucial for the recruitment and retention of B1 
and B2 cells in the peritoneum. Inflammation-induced formation of FALCs required TNF 
expression by myeloid cells and TNFR-signalling in stromal cells. Peritoneal immunization 
with T-independent and T-dependent antigens induced B cell differentiation into plasma 
cells and germinal centre (GC)-like B cells in FALCs indicating an important function of 
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these clusters during immune responses. Finally, we show that invariant Natural Killer T 
(iNKT) cells, a subset of T cells enriched in adipose tissues, and IL-13 played a key role in 
inflammation-induced FALC formation. 
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RESULTS 
 
Visualisation and characterisation of FALCs 
 
The anatomical distribution of FALCs in adipose tissue renders impractical the methods 
generally used for the visualisation and isolation of lymphoid structures (cryo-sections and 
paraffin embedded sections). We therefore performed whole-mount immunofluorescence 
staining of the main VAT found in the peritoneal and pleural cavities, which allowed, with a 
fluorescence stereomicroscope, the visualisation (Fig. 1a) and enumeration of the CD45+ 
cell clusters present in the omental, gonadal, mesenteric, mediastinal and pericardial 
adipose tissue. In the peritoneal cavity, the omentum was the fat depot with the highest 
density of lymphoid clusters (8000 clusters/g) with a mean of 80 milky spots per omentum. 
The density of FALCs was highest in the mesenteric fat depot (120 clusters/g with a mean 
of 16 clusters per mesentery) but was very low in the gonadal adipose tissue (8 clusters/g) 
with a mean of 1-2 clusters per depot  (Fig.1b-c). In the pleural cavity, the fat depot with 
the highest density of lymphoid clusters was the pericardium (5400 clusters/g) with a mean 
of 40 clusters per pericardium. The mediastinum with a density of 2100 clusters/g and a 
mean of 9 clusters per mediastinum, accounts for the rest of the FALCs in the pleural 
cavity (Fig.1b-c). This analysis revealed the high heterogeneity in the lymphoid cluster 
content of adipose tissues, ranging from complete absence or very low numbers in the 
case of the subcutaneous adipose tissue and gonadal adipose tissue, respectively, to a 
very high density in the case of the omentum, the pericardium and mediastinum. The 
omentum and the pericardium contained approximately eighty per cent of the lymphoid 
clusters in the peritoneum and pleural cavities respectively, while the rest of the clusters 
are present in the gonadal adipose tissue and the mediastinum (Fig 1c).  
 
 The cellular composition of the clusters was determined using a combination of 
stains with fluorescent Abs followed by isolation with a stereomicroscope and further 
confocal microscopy analysis. In resting conditions the clusters were mostly composed of 
IgM+ B cells, with few CD4+ T cells and very low numbers of CD11b+ myeloid cells (Fig. 1d 
and Sup. Fig.1). Clusters of different sizes and degrees of B-T cell segregation could be 
observed in individual mice and in different fat depots with the largest clusters presenting a 
core of T cells surrounded by B cells (Sup. Fig.1). The high level of IgM expression on a 
fraction of B cells combined with the expression of CD11b on some of these IgMbright B 
cells indicated the presence of B1 cells. We did not detect any differences in the 
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hematopoietic composition of FALCs from the mesenteries, mediastinum or pericardium 
that resembled the milky spots of the omentum (not shown). FALCs appeared to be highly 
vascularised, as shown by the presence of CD31+ blood vessels. However, no clear 
connection with Lyve-1+ lymphatic vasculature could be detected. Only scattered Lyve-1+ 
macrophages were seen in close proximity of FALCs (Fig. 1e). 
The mesenteric adipose tissues, where FALCs were easier to identify and 
enumerate, were used in the rest of the study to analyse the development and function of 
these structures. FALC formation was initiated after birth, with the first clusters identified in 
the mesenteries of two- to three-week old animals and their number increasing to reach a 
plateau at around 18 weeks of age (Fig 1f).  
 
CXCL13 is highly expressed by stromal cells in FALCs 
 
To understand how B and T cells were recruited to the FALCs, we assessed the 
expression of the homeostatic chemokines Cxcl13, Ccl21 and Ccl19 as well as the 
cytokine Il-7 by qPCR analysis in isolated clusters as described in materials and methods. 
Cxcl13 expression was found to be particularly high in FALCs compared to the associated 
adipose tissue (>100 fold) or lymph nodes (LN) (10 fold). In contrast, Ccl21, Ccl19 and Il-7 
transcripts were not enriched in FALCs compared to the other tissues analyzed (Fig. 2a). 
In agreement with these results, the number and composition of FALCs in CCL21- and 
CCL19-deficient mice (Plt/plt) and Ccr7-/- mice presented no differences with their WT 
counterparts (Fig. 2b-c). Tnf and Ltβ transcripts were both highly expressed in FALCs, 
which might reflect the high content of B cells in these clusters.  
 We further characterised the expression of CXCL13 in FALCs by immuno-
fluorescence staining. We observed CD45-CXCL13+ stromal cells with an elongated 
morphology were present in the clusters (Fig. 2d) and resembled Follicular Dendritic Cells 
(FDCs).  This prompted us to test whether LTβR and/or TNFR signalling were involved in 
inducing the expression of this chemokine, as is the case for spleen and LN FDCs21-23. 
However, we observed that CXCL13+ cells were present in FALCs of Ltβr-/- and Tnfr1/2-/- 
mice, demonstrating that the expression of this chemokine by FALC stromal cells is 
independent of signals induced by these receptors (Fig. 2d). CXCL13+ cells were also 
found in FALCs of Rag2-/- mice, indicating that signals delivered by B and T cells were not 
involved in the induction/maintenance of CXCL13 expression in these structures24, 25. 
 To test whether CXCL13 expression is the basis of the recruitment of B cells in 
FALCs, we analysed cluster formation in the Cxcr5-/- mice, which are deficient for the 
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CXCL13 receptor. We found a normal number of FALCs forming in the mesenteries of 
these mice, but as expected a marked reduction in the B cells present in the clusters. This 
indicated that CXCL13 was not important for FALC formation but was essential for the 
recruitment of B cells (Fig. 2c-d). The mesenteries together with the omentum were 
previously identified as an important source of CXCL13 for the retention of B cells in the 
peritoneal cavity. Overall, we demonstrate that the presence of CXCL13 in the 
mesenteries is due to its specific expression by FALC stromal cells and not the 
surrounding adipose tissue. 
 
FALCs support B cell proliferation and differentiation during peritoneal immune 
challenges 
 
B1 cells are important for immune responses against T-independent (TI) antigens2, 5, 26-31. 
Therefore, to assess B cell responses in FALCs, we used the TI antigen 4-hydroxy-3-
nitrophenylacetyl (NP)-Ficoll to immunise QM/QM (IgHNP/NP Igκ-/-) mice, which have a 
quasi-monoclonal primary B cell repertoire specific for NP32. We compared the proliferative 
response of B cells in FALCs, the peritoneal cavity, and the spleen in response to NP-
Ficoll by determining the percentages of Ki67+ B cells, 24 hours post intra-peritoneal (IP) 
immunisation, in enzymatically digested mesenteries (mesenteric LNs carefully removed), 
the peritoneal cavity lavage and the spleen. We found that both B1 and B2 cells rapidly 
started to proliferate in the mesenteries. Interestingly, the percentages of Ki67+ 
proliferating B1 cells in the mesenteries was three times higher than the level of 
proliferation found in the peritoneal cavity lavage or the spleen, reaching 70% for B1a, 
50% for B1b and 40% for B1c cells. Up to 40% of B2 cells also proliferated in response to 
NP-Ficoll (Supp. Fig. 2a-b). Whole mount staining of the mesenteries 24 hours after 
immunisation showed that the majority of B cells were located in FALCs and not dispersed 
in the adipose tissue. Moreover, FALCs showed a marked enlargement in their size and 
an increased level of IgM staining (Supp. Fig. 2c). Collectively, results from flow-cytometric 
and confocal analysis indicated that B cells were actively proliferating in FALCs. To 
confirm that FALC B cells were actively secreting IgM, we assessed the number of 
antibody-forming cells (AFC) four days after NP-Ficoll IP immunisation. To do this QMxB6 
(IgHNP/wt Igκ-/wt) mice33 were used, which contain 5% of NP-specific B cells. ELISpot 
analysis of cells isolated from the immunised animals confirmed an expansion of NP-
specific B cells expressing IgM (Fig. 3a top). We also found a significant increase in cells 
that have undergone switching to IgG in FALCs and spleen (Fig. 3a bottom and Fig. 3b). 
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Further evidence of B cells undergoing Ig switching in FALCs was obtained by NP-Ficoll 
immunisation of Cγ1-CrexQMmTmG mice (IgHNP/Cγ1Cre Igκ-/-, mTmG+/wt). These mice carry 
one copy of the Cre recombinase in the IgG1 heavy chain gene, induced during activation 
of Ig class switching34, in combination with one copy of the NP-specific heavy chain from 
QM mice and the mTmG reporter35. This showed clusters of B blasts or plasmablasts that 
had undergone induction of Ig class switch recombination (Green) further supporting the 
ELISpot results (Fig. 3b). The early and preferential proliferation of B1 cells in FALCs, and 
the presence of IgM and IgG producing cells demonstrated that these clusters contribute 
to peritoneal cavity B1 cells immune responses to type II antigens.  
The role of FALCs in T-dependent immune responses was tested by intra-venous 
(IV) adoptive transfer of peritoneal lavage cells from QM/QM (IgHNP/NP Igκ-/-)EYFP+/- mice 
into C57BL/6J recipients that were subsequently IP immunised with Alum precipitated-NP-
OVA (Fig 3c). Flow cytometric analysis of cells isolated eight days after immunization 
showed a statistically significant increase in the frequency and number of Ag-specific B 
cells and CD38-GL7+ GC-like B cells in FALCs, spleen and mesenteric (m)LNs (Fig 3d-e 
and data not shown). An endogenous immune response was elicited by IP immunising 
C57BL/6J mice with Alum precipitated-Phycoerythrin (PE). In agreement with the results 
above, flow-cytometric analysis of FALCs, spleen and mLN showed a 20x increase in the 
proportion and number of PE-specific B cells and GC-like B cells (Fig 3f-h and data not 
shown). Taken together, these results indicate that FALCs act as true lymphoid tissues by 
supporting early activation of B cells during inflammation and differentiation towards 
plasma cells and germinal centre cells during adaptive immune responses in the 
peritoneal cavity.  
 
FALC development is regulated by unique cellular and molecular mechanisms that 
are independent of LTi cells and the LTβR pathway. 
 
The development of LNs and Peyer’s patches is dependent on the activity of LTi cells and 
engagement of the LTβR18-20. To determine whether the formation of FALCs followed the 
same cellular and molecular cues, we assessed the presence of these clusters in the Ltβr-
/-, Ltα-/- and Rorc-/- mouse strains in which LN development is fully impaired36-38. We found 
no differences in the number and composition of FALCs in these strains compared to WT 
mice, indicating that the development of these clusters was independent of both LTi/ILC3 
cells and LTβR engagement (Fig. 4a-b). To determine whether any other lymphoid cell 
type was involved in FALC formation, we analyzed the presence of these structures in 
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Rag2-/- mice, lacking lymphocytes, and the Rag2-/-γc-/- mice that are deficient in 
lymphocytes and ILCs. We found that while FALCs were present in normal numbers in 
Rag2-/- mice; they were absent in Rag2-/-γc-/- mice revealing a potential requirement for 
ILCs and/or NK cells to initiate cluster formation. Il15-/- mice have similar FALC numbers to 
their WT counterparts, ruling out a role for NK cells in the formation of these clusters (data 
not shown). Flow cytometric analysis of VAT in WT and Rag2-/- mice demonstrated the 
presence of Lin-c-Kit+Sca-1+IL-7Rα+ ILCs type 2 (Supp. Fig 3a). In addition, more than 
80% of the Lin-CD90+Sca-1+NK1.1- cells present in FALCs of Rag2-/- mice correspond to 
ILC2 cells further confirming the presence of these cells in the clusters14 (Supp. Fig 3b). 
Moreover, immunofluorescence staining of mesenteries of Rag2-/- mice identified clusters 
of CD90+CD11b- cells in FALCs, that in the absence of T cells are likely to correspond to 
ILCs (Supp. Fig 3c).  
As the LTα-LTβR pathway was not required for the formation of FALCs, we 
examined the role of TNF, another key regulator of lymphoid tissue organization22, 23, 39. In 
the double knockout mouse model for its receptors TNFR1 and TNFR2 (Tnfr1/2-/-), we 
observed a two-fold reduction in the number of FALCs as well as a general decrease in 
the size of the clusters (Fig. 4a-b). Conversely, in the Tnf+/ΔARE mice, which carry a 
deletion that results in the accumulation of Tnf mRNA and protein, and the development of 
inflammatory diseases40, we observed an eight-fold increase in FALC number and in the 
size of the clusters with respect to those present in WT littermates (Fig. 4a-b). Thus, we 
conclude that TNF signalling promoted the formation of FALCs.  
 Colonisation by the commensal flora is involved in the postnatal development and 
maturation of the Gut Associated Lymphoid Tissues (GALT)41-44. The postnatal 
development of FALCs suggested a similar mechanism. Indeed, Germ Free (GF) mice 
showed a two-fold reduction in the number of FALCs indicating that the commensal flora 
partly contributed to their formation (Fig. 4a-b). Overall, these analyses revealed that the 
formation of FALCs is entirely dependent on an innate lymphoid cell type different from LTi 
cells and other RORγt+ ILC3 cells and partly dependent on TNF signalling and colonisation 
by the commensal flora. 
 
Peritoneal inflammation led to rapid formation of FALCs 
 
Since the formation of FALCs was increased in Tnf+/ΔARE mice, we tested the effect of 
acute sterile peritonitis on FALC formation. Peritoneal inflammation driven by Zymosan led 
to a marked increase in the size and number of FALCs at day 3, with the clusters 
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becoming visible without counterstaining under the dissecting microscope (Fig. 4c) and 
their numbers doubling (Fig. 4d). The increase in size and number of the clusters was 
associated with a pronounced alteration in their composition. We found that inflammation 
induced a significant recruitment of CD11b+ myeloid cells (Fig. 4e). Further immuno-
fluorescence staining showed that the myeloid cells whithin FALCs were mostly Gr1low/-
Ly6Clow/-F4/80+ macrophages (Supp. Fig. 4). These observations indicate that FALC 
formation is inducible and that peritoneal inflammation leads to a general expansion and 
formation of the lymphoid clusters associated with VAT. 
 
TNF expression by myeloid cells and TNFR1/2 signalling on stromal cells are 
necessary for FALC formation upon inflammation 
 
Experiments with Zymosan revealed that formation of FALCs could be induced in adult 
mice by inflammation. The pro-inflammatory cytokine TNF, which promoted the formation 
of FALCs in non-immunised mice (Fig. 4a-b), was a strong candidate to be involved in the 
induction of these clusters upon inflammation. Immunisation with Zymosan in the Tnfr1/2-/- 
mice failed to induce de novo formation of clusters at day 3 post-injection as in WT mice, 
even though existing FALCs increased in size and recruited CD11b+ myeloid cells (Fig. 
5a).  
 We then asked whether TNF-R-signalling was required on stromal cells to induce 
formation of FALCs following Zymosan injection. To address this question WT and Tnfr1/2-
/- mice were lethally irradiated and reconstituted with WT bone marrow cells to generate 
WT/WT and WT/Tnfr1/2-/- chimeras. Upon reconstitution both groups of chimeric mice 
received an IP injection of Zymosan. We found that reconstitution of Tnfr1/2-/- mice with 
WT bone marrow was not sufficient to rescue FALC formation upon inflammation at day 3 
post-injection. Inflammation led to an enlargement of FALCs and recruitment of myeloid 
cells but failed to induce the formation of more clusters as it did in the control WT bone 
marrow chimeras (Fig. 5b). Thus, our data indicate that radiation resistant stromal cells 
respond to TNF and induce FALC formation. 
 We next determined the cellular origin of TNF, using mouse strains with specific 
deletion of Tnf in either CD4+ T cells (T-TNF, CD4-Cre), B cells (B-TNF, CD19-Cre) or 
macrophages/neutrophils (M-TNF, LysM-Cre)45. Specific ablation of Tnf in T and B cells 
did not impair the induction of cluster formation upon inflammation as seen by the 3- and 
2-fold increase in cluster numbers observed in T-TNF and B-TNF mice respectively (Fig. 
5c). In contrast, loss of Tnf expression by neutrophils and macrophages in M-TNF mice 
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resulted in the absence of new FALC formation following Zymosan injection, even though 
CD11b+ myeloid cells were recruited to the clusters (Fig 5c). We then analysed by intra-
cellular flow-cytometric staining the cellular origin of TNF in the mesenteries following 
Zymosan injection. As expected most of TNF+ cells were of myeloid origin (data not 
shown) with 40% of F4/80+ macrophages and Ly6ChighF4/80- monocytes displaying intra-
cellular TNF expression (Fig. 5d). Once correlated to their cell number, macrophages 
represented 60% of all TNF+ myeloid cells in the mesenteries (Fig. 5d).  
 Taken together, these results demonstrate the importance of TNFR1/2 signalling in 
stromal cells for de novo formation of FALCs upon inflammation and that macrophages 
are a key source of TNF.  
 
CD1d-restricted NKT cells are necessary for FALC formation upon inflammation. 
 
Given the prevalence of B cells in FALCs, we evaluated their role in the formation of these 
clusters upon inflammation. To do so, we analysed the effect of IP injection of Zymosan in 
Rag2-/- mice, lacking T and B cells, and in μMT-/- mice that are deficient in B cells. 
Unexpectedly, we found that B cells were not involved in FALC formation upon 
inflammation as shown by the three-fold increase in their number (Fig. 6a) and the 
recruitment of CD11b+ myeloid cells after inflammation in these mice (Fig. 6b). However, 
peritoneal inflammation failed to induce cluster formation in Rag2-/- mice indicating that a T 
cell subset was necessary for neo-formation of FALCs upon inflammation (Fig. 6a). This 
result was confirmed by the absence of new cluster formation after Zymosan injection, in 
CD3εtg26-/- mice, in which the development of T, NK and NKT cells is blocked. In both 
Rag2-/- and CD3εtg26-/- mice, inflammation induced a normal recruitment of myeloid cells in 
FALCs (Fig. 6a-b).  
 We further characterised the role of T cells in FALC formation upon inflammation by 
examining the effect of Zymosan injection in Tcrδ-/- mice, which lack γδ T cells. 
Remarkably, Zymosan induced a five-fold increase in FALC numbers in Tcrδ-/- mice 
compared to a two-fold increase in WT mice, indicating that γδ T cells are not necessary 
for FALC formation following inflammation. In contrast, γδ T cells might have a regulatory 
role in the formation of the clusters (Fig. 6a-b).  
 We next assessed the role of CD1d-restricted Natural Killer T (NKT) cells in 
inflammation-induced FALC formation. We found that the number of FALCs was 
decreased two-fold in Cd1d-/- mice compared to WT mice and that injection of Zymosan 
failed to induce cluster formation at day 3 post-injection in this mutant strain (Fig. 6a-b). 
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This result indicated an important role for NKT cells in FALC formation during homeostasis 
and upon inflammation. 
 
Activation of iNKT cells induces FALCs formation 
 
NKT cells recognise lipid-based antigen presented by CD1d. The best characterised NKT 
cell population is Type I CD1d-restricted NKT cells, also known as invariant NKT cell 
(iNKT), in reference to their invariant TCR α-chain usage (Vα14-Jα18 in mice). Type I NKT 
cells recognise and strongly respond to the synthetic glycolipid α-Galactosylceramide 
(αGalCer) presented on CD1d28. A number of studies have recently described the 
presence of iNKT cells in adipose tissue and their role in regulation of metabolism46-50. 
Flow cytometric analysis of Type I NKT cells confirmed that these cells were particularly 
enriched in adipose tissue representing up to 6% of all lymphocytes, compared to the 
spleen (up to 0.3%) or the mLN (up to 0.1%) (Fig. 7a). Since it is not possible to detect 
iNKT cells by immuno-fluorescence, we transferred CFSE-labelled iNKT into WT mice and 
showed that these cells were indeed recruited to FALCs (Fig. 7b). 
We next tested the effect of iNKT cell activation on FALC formation by IP injection 
of αGalCer into WT mice and showed a two-fold increase in the number of clusters in 
animals injected with this glycolipid compared to control littermates that received vehicle. 
This demonstrated that direct TCR activation of iNKT cells was sufficient to induce cluster 
formation (Fig. 7c). Since we found that Zymosan-induced FALC formation was dependent 
on TNFR1/2 signalling, we assessed whether these pathways were also required for 
cluster formation following iNKT cell activation via αGalCer. We showed that FALC 
formation upon αGalCer injection was indeed abrogated in Tnfr1/2-/- mice, indicating the 
need for signalling through these receptors (Fig. 7d). While IP injection of αGalCer induced 
a marked increase in the levels of CD69 and CD25 on iNKT cells, Zymosan did not appear 
to have a similar effect (data not shown).  
 To test whether iNKT cells were sufficient to rescue inflammation-induced FALC 
formation in Rag2-/- mice, we transferred sorted splenic iNKT cells by IP injection in these 
mice, 24 hours before immunisation with Zymosan. Our results showed that only mice that 
received iNKT cells responded to the Zymosan injection by presenting with an increase in 
FALC numbers (Fig. 7e). In contrast, mice receiving CD3high cells, that do not contain NKT 
cells, were not able to rescue FALC formation following inflammation.  
 We next tested the effect of the selective loss of Type I iNKT cells on the formation 
of FALCs upon Zymosan-induced inflammation. We found that FALC numbers were 
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normally increased two-fold in Jα18-/- mice following Zymosan injection (Fig. 7f) indicating 
that Type I iNKT cells were not absolutely required for formation of these clusters. Taken 
together, these results indicate that even though Type I iNKT cells were sufficient to 
restore cluster formation in Rag2-/- mice, the function of Type I and Type II iNKT cells 
appear to be overlapping during inflammation-induced FALC formation. 
 
Formation of FALCs upon inflammation is dependent on IL-4Rα signalling 
 
Upon activation, iNKT cells produce very rapidly large amounts of Th-1 and/or Th-2 type 
cytokines, that link innate and adaptive immune responses and play important immuno-
regulatory functions28. To understand the involvement of Th1 and Th2 cytokines in 
inflammation-induced FALC formation, we tested the effect of Zymosan-induced 
inflammation in mice deficient in either of these cytokines. We found that FALC formation 
induced by the injection of Zymosan was not impaired in Ifnγ-/- mice, indicating that the 
prototypic Th-1 type cytokine does not appear to be required for this process (Supp. Fig 
5). 
 In contrast, Zymosan injections failed to induce formation of new clusters at day 3 
post-injection in Il4rα-/- mice, where signalling by IL-4 and IL-13 is impaired, while the 
BALB/c WT mice responded with a two-fold increase in the number of FALCs (Fig. 8a-b). 
Additionally, we noticed that FALC numbers were two-times higher in the BALB/c mouse 
strain compared to the C57BL/6J strain, suggesting that the Th2 bias shown in the former 
during immune responses contributes to the higher number of FALCs found in this genetic 
background. To determine the respective contribution of IL-4 and IL-13, we assessed the 
formation of FALCs upon inflammation in the Il4-/- and Il13-/- mouse strains. We found that 
Zymosan injection led to the formation of new clusters in both mutant strains, suggesting 
that IL-4 and IL-13 were exerting redundant functions in FALC formation upon 
inflammation in the BALB/c background (Fig. 8a-b). However, IL-13 played a critical role in 
inflammation induced FALC formation in the C57BL/6J background as shown by the 
absence of cluster formation in Il13-/- mice at day 3 post-injection (Fig. 8c). To test whether 
IL-13 produced by iNKT cells was sufficient to rescue inflammation-induced FALC 
formation in Il13-/- mice, we transferred sorted splenic iNKT cells into these mice, 24 hours 
before immunisation with Zymosan. We found that IL-13-sufficient iNKT cells induced a 
slight increase in FALC numbers in Il13-/- mice but this did not reach statistical significance 
(Fig. 8c). These results indicate that IL-13 contributes to inflammation-induced FALC 
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formation, but that iNKT production of this cytokine is not sufficient for this process and an 
additional source of IL-13 may be required.  
 We finally assessed the role of IL-4Rα signalling in the formation of FALCs driven 
by direct iNKT cell activation via αGalCer injection. αGalCer injection failed to induce 
FALCs formation in Il4rα-/- mice indicating that formation of FALCs through direct activation 
of iNKT cells also required IL-4Rα signalling (Fig. 8d). 
 
IL-4c induces a partial rescue of inflamation-induced FALC formation in the absence 
of TNF signalling   
 
Our results showed that TNF- and IL-4-signals are necessary for inflammation-induced 
FALC formation. To get insight into the levels of interaction of the signals induced by these 
cytokines, we performed a serie of combinatorial and rescue experiments. As shown in 
Supp. Fig. 6a, injection of TNF and IL-4 complex (IL-4c) on their own or together was not 
sufficient to induce cluster formation, indicating that other factors were involved in this 
process. Next we tested whether IP injection of TNF could rescue Zymosan-induced FALC 
formation in Il-4r-/- mice. Our results show no significant increase in the number of clusters 
induced by Zymosan in this mutant strain. In contrast, IP injection of IL-4c in Tnfr1/2-/- mice 
induced a small but significant increase in the number of Zymosan-induced FALCs, 
indicating that IL-4 could partially rescue cluster formation in Tnfr1/2-/- mice and suggesting 
that IL-4 may act downstream of TNFR1/2 signalling (Supp. Fig. 6b).  
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DISCUSSION 
 
In this report we defined the requirements for the formation of a new type of 
lymphoid tissue called Fat Associated Lymphoid Clusters. These non-conventional 
lymphoid clusters developed in close association with VATs of the peritoneal and pleural 
cavities. We showed that in the peritoneal cavity, mesenteric FALCs and omental milky 
spots accounted for the quasi-totality of the lymphoid clusters associated with adipose 
tissue. We uncovered the previously unappreciated abundance of FALCs in the 
pericardium and mediastinum of the pleural cavity where the density of lymphoid clusters 
approached the levels found in the omentum. Microscopic analysis of FALCs revealed a 
high B1 cell content with no apparent B and T cell segregation, comparable to what has 
been reported previously for the milky spots of the omentum12. FALCs expressed high 
levels of CXCL13 required for efficient recruitment of B cells, which upon immune 
challenge with T-dependent or -independent antigens actively proliferate, undergo 
differentiation towards plasma cells or GC cells in these clusters. The function of FALCs 
and milky spots are probably overlapping in the peritoneal cavity, but FALCs contained in 
the mediastinal and the pericardial fat are likely to be the main sites for the organization of 
immune responses and for retention of B1 cells by CXCL13 in the pleural cavity. 
FALC development in mice was constitutive and its initiation coincided with 
weaning. Establishment of a normal number of FALCs in adult mice was dependent on 
TNFR1/2 signalling and colonisation by commensal flora suggesting a role for Pattern 
Recognition Receptors. FALCs were totally absent in Rag2-/-γc-/- mice and 
immunofluorescence and flow-cytometric analysis in Rag2-/- mice indicated that cells 
present in the clusters in absence of T and B cells were ILCs. Importantly, FALC formation 
was independent of the presence of LTi cells and other ILC3 cells as well of LTα-LTβR-
signalling which resembles the formation of nasal associated lymphoid tissues (NALT)51.  
Although we have developed a number of ILC2-deficient mouse strains52, 53 these mice still 
have residual numbers of ILC2-like cells and we have not been able to show categorically 
whether these cells play a role in FALC formation (data not shown).  
Peritoneal inflammation induced a rapid neo-formation of a large number of FALCs 
reaching a two- to three-fold increase compared to the number of clusters present in 
resting conditions. This effect was dependent on TNF expression by myeloid cells and 
TNFR1/2 signaling on stromal cells. We further showed that most TNF producing cells in 
the mesenteries are macrophages. In addition to the innate requirement for TNF+ myeloid 
cells, neo-formation of FALCs necessitated the activation of iNKT cells and signalling 
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through the IL4Rα. Our data also demonstrated that IL-13 contributed to inflammation-
induced FALC formation. Interestingly, triggering of iNKT cells through TCR ligation was 
sufficient to induce formation of FALC that was also dependent on TNFR1/2 and IL-
4Rα signalling. Therefore, induction of FALC formation seems to require both an 
inflammatory signal, delivered by TNF, and a Th2/Resolution signal transduced by IL-4Rα. 
The fact that IL-4c can partially rescue FALCs formation upon Zymosan injection indicates 
that IL-4Rα signals could be acting downstream of the TNF receptors. How FALC 
formation is timed with the iniation of the resolution of inflammation and whether FALCs 
play a role in the resolution phase remains to be investigated. 
 We thus propose a multistep model where FALC development starts after birth with 
the clustering of immune cells in VAT (See model Fig. 8e). Colonization by the microbiota 
induces TNF that upon engagement of the TNF receptors results in the expression of IL-
4Rα ligands that are required for the expansion of the number of FALCs to the levels seen 
in adult mice. This model is in agreement with a recent report showing that TNF-signalling 
induces IL-13 expression on adipocytes during diet-induced obesity54. Expression of 
CXCL13 by stromal cells results in the recruitment of B cells. Peritoneal inflammation 
induces a rapid increase in the size and number of FALCs that is dependent on TNF-R 
signalling on stromal cells as well as IL-4R mediated signals and NKT cell activation. 
Moreover, FALCs support Ag-specific B cell recruitment, proliferation and differentiation. 
ILC2 express high levels of IL5 that might drive the proliferation of B1 cells in the 
clusters55. Coupling of inflammation and rapid FALC formation provide a platform to link 
innate and adaptive immune responses that support rapid B cell proliferation and natural 
antibody secretion in the body cavities following infection. 
We and others have recently shown that adipose tissues constitute an important 
reservoir of stem cells for the formation of lymphoid stroma in LNs during development22, 56 
and immune responses57. It is thus conceivable that FALC stromal cells originate from 
adipose tissue stem cells or peri-vascular cells, as has been recently shown for FDCs22. 
FALC stromal cells expressed high levels of CXCL13 but were negative for CD21/35.  
Different populations of macrophages, Treg cells, NKT cells, B cells, ILCs and 
eosinophils have been described to be present in the peritoneal cavity and their metabolic 
regulatory functions are increasingly studied58-60. The relation between these cell 
populations and FALCs will require further studies to be elucidated.  
This work constitutes the first report of NKT cells having a lymphoid organogenic 
activity. Not only were NKT cells necessary for the formation of FALCs during 
inflammation, but also their sole activation was sufficient to induce neo-formation of 
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clusters. A number of studies have recently highlighted the role of NKT cells in the 
regulation of adipose tissue metabolism in normal nutrient homeostasis and during 
obesity46-50. Whether the metabolic activity of NKT cells is linked to their capacity to induce 
FALC formation and alter the homeostasis of other hematopoietic cells present in adipose 
tissues remains to be investigated.  
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MATERIALS AND METHODS 
 
Mice 
C57BL/6J (H-2b), Ltβr-/-, Ltα-/-, Rorc-/-, Rag2-/-, Rag2-/-γc-/-, Tnfr1/2-/-, Tnf+/ ΔARE36, and Eyfp-
Rosa 2655, Plt/plt, Ccr7-/-, Cxcr5-/-, QM/QM (IgHNP/NP Igκ-/-), QMxB6 (IgHNP/wt Igκ-/wt),  
QM/QM (IgHNP/NP Igκ-/-)EYFP+, Cg1-CrexQMmTmG (IgHNP/Cγ1Cre Igκ-/- mTmG+/wt), Cd3εtg26-
/-, Cd1d-/-, TNFfl/flLysM-Cre (M-TNF)45, TNFfl/flCD4-Cre (T-TNF)45 or TNFfl/flCD19-Cre (B-
TNF)45, Vα14 transgenic, Ifnγ-/- (on C57BL/6J background), Il4-/- (on BALB/c background) 
and BALB/c (H-2d) mice were bred and maintained under specific pathogen-free 
conditions. Il13-/-, and Il4rα-/- mice were used in C57BL/6J or BALB/c background for 
experiments as indicated. Germ-free C57BL/6J mice were obtained from the Institut 
Pasteur, Paris, France. Bone marrow chimeras were generated after irradiation of 
C57BL/6J and Tnfr1/2-/- mice and reconstitution with bone marrow from C57BL/6J. All 
experiments in this report were performed according to UK Home Office and local ethics 
committee regulations. 
 
Immunization and peritoneal cavity inflammation 
QM/QM (IgHNP/NP Igκ-/-), QMxB6 (QMIgH/wt Igκ-/wt), and Cγ1-CrexQMmTmG mice were 
immunised by IP injection of 30 mg NP40-Ficoll per mouse (Biosearch Technologies, 
Novato, CA, USA). B cell activation from mesenteries, spleen, mLN and peritoneal cavity 
lavage was assessed 24 hours later (QM/QM mice) or 4 days latter (QMxB6 and Cγ1-
CrexQMmTmG mice) by flow cytometry and ELISpot. IgG1 switching in the mesenteries 
was visualized at day 4 by wholemount stereo-microscopy. For the cell transfer 
experiment, 2.106 peritoneal lavage cells from QM/EYFP+ (QM/QM (IgHNP/NP Igκ-/-)EYFP+) 
mice were transferred IP into recipient C57BL/6J mice, before immunization with NP-OVA 
(50 mg) precipitated with Alum on the next day. B cell activation was assessed at day 8 in 
the mesenteries, spleen and mLN. For the PE immunization experiment, C57BL/6J mice 
were immunized IP with Phycoerythrin (PE) (50 mg) and B cell activation was analysed at 
day 8-9 in the mesenteries, spleen and mLN. Peritoneal cavity inflammation was induced 
by IP injection of 1mg Zymosan (Sigma). 72 hours later, B cell activation was assessed by 
flow cytometry, FALC number and composition were assessed by whole mount 
fluorescence staining and confocal analysis. Treatment of mice with IL-4c was performed 
as previously described61. IL-4c consisted of a 2:1 molar ratio of recombinant mouse IL-4 
(Peprotech) and anti-IL-4 mAb (clone 11B11;BioXcell). Mice were injected i.p. with IL-4c 
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containing 5 µg of IL-4 and 25 µg of 11B11, or PBS vehicle control on days 0 and 2. For 
co-administration experiments with Zymosan, mice were given 1mg Zymosan on day 0 
with IL-4c on day 0 and day 2. Mice were treated with 1ug TNF (Peprotech) or PBS control 
on day 0 and day 2. For co-administration experiment with IL-4c, mice were treated with 
IL-4c and TNF on day 0 and day 4. For co-administration experiment with Zymosan, mice 
were given 1mg Zymosan on day 0 and TNF on day 0 and day 2. In all experiments with 
IL-4c and TNF, analysis of the mesenteries was performed on day 4. 
 
Cell isolation and cell sorting  
For flow cytometric analysis of the mesenteries, tissues were digested for 30 minutes in 
RPMI containing 1% fetal calf serum and 1mg/ml Collagenase D (Roche) at 37°C on 
constant agitation (110 rpm). Tissue suspensions were filtered was filtered through 40µm 
cell strainers before staining. Peritoneal cavity lavage was performed by injection of 5ml 
cold PBS in the peritoneal cavity. /,)0&,+,#/-)"+&  & "))/+!%&$% "))/3/
-".#,.*"! 2&,),3 (,40,*0&,+  ")) /,.0&+$   "))/ -1.&04 3"."
&+'" 0"! &+ 0%"-".&0,+") 2&04,#	
%,1./"#,." &+!1 0&,+,#-".&0,+") 2&04
&+#)**0&,+"/"+0".&"/3"."+)45"! #,. )1/0". #,.*0&,+
%,1./ )0".,.
)")&+$& "))/3"." "))/,.0"!#.,*0%"/-)""+,#Vα14 transgenic mice in which 
30-40% of all cells are positive for αGalCer-loaded CD1d tetramers and 3"."
&+ 10"!#,.	*&+10"/03&0%µ"&,/ &"+ "/  ,.!&+$0,*+1# 01.".
&+!& 0&,+/-.&,.0,&+'" 0&,+ CD1d-PBS57 loaded tetramers were kindly provided by the 
National Institutes of Health Tetramer Facility (Atlanta GA, USA). 
 
FALC isolation  
Clusters were isolated using a fluorescent stereomicroscope from unfixed mesenteries of 
Eyfp+ mice in which the bright EYFP+ lymphoid aggregates could be visualised without 
prior fluorescent staining. Isolated clusters were used for qPCR analysis. 
 
Antibodies and reagents for flow cytometry 
Antibodies and reagents used for flow cytometry are listed in Supplementary Table 1. 
Single cell suspensions were stained with primary conjugated antibodies followed by 
secondary antibodies. NP-specific B cells were detected with NP-PE, added with the 
primary antibody staining mix. iNKT cells were detected with CD1d tetramer conjugated 
with APC preloaded with PBS-57 (an analog of α-GalCer). CD1d-PBS-57-APC was also 
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added to the primary antibody staining mix. For Ki67 nuclear staining, cells were fixed and 
permeabilized with the Foxp3 Fixation/Permeabilization kit (eBiosciences). Flow cytometric 
analysis was performed using Cyan (BD Biosciences) with forward/side scatter gates set 
to exclude non-viable cells. Data were analyzed with FlowJo software (version 8.8.3, Tree 
Star). 
 
ELISpots 
2.5x105 cells from the mesenteries or spleen were seeded into precoated NP15-BSA 
(5µg/ml)- nitrocellulose microtiter plates. After 24h culture the plates were washed and 
incubated in isotype specific alkaline phosphatase-conjugated antibody IgM-AP1/ IgG-AP1 
(SouthernBiotech) diluted in PBS-1%BSA for 2 hours at RT and colorated using Fast 
BCIP/NBT alkaline phosphatase substrate (Sigma). Spots were counted using an AID 
ELISpot reader (Autoimmun Diagnostika GmbH, Strassburg, Germany) with Eli4 software 
(Autoimmun Diagnostika GmbH). 
 
RT-PCR and real-time RT-PCR 
mRNAs were isolated from tissues using the RNeasy mini kit (Qiagen), and reverse 
transcription was performed using the High capacity reverse transcription cDNA synthesis 
kit (Applied Biosystems). Quantitative RT-PCR was performed using primers and probes 
from Applied Biosystems for Cxcl13 (Mm00444533_m1), Ccl21 (Mm03646971_gH), Ccl19 
(Mm00839967_g1), Tnf (Mm00443258_m1), LTβ (Mm00434774_g1) and Il-7 
(Mm01295803_m1) using ABI PRISM 7900HT instrument. The means of duplicate of the 
ratio of the gene of interest to β-actin are shown.  
 
Immunofluorescence staining 
After dissection, whole mesenteries were fixed in PBS 4%PFA for 1 hour at 4°C, 
permeabilized in PBS 1%Triton for 30 minutes at room temperature (RT). Tissues were 
then stained with primary antibodies for 1 hour at RT on constant slow agitation. After 
wash, tissues were stained with secondary antibodies for 30 minutes at RT. Antibodies 
used are listed in Supplementary Table 1. Tissues were mounted using Vectashield 
mounting medium (Vector Laboratories). 
 
Image acquisition and analysis of confocal images 
Confocal images were acquired using a Zeiss LSM 510 laser scanning confocal head with 
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a Zeiss Axio Imager Z1 microscope. For all analysis of clusters a minimum of 12 clusters 
were analysed from 4 mice of each group and pooled from 2 independent experiments. 
 
Statistical analysis 
00&/0& ) /&$+&#& + " 3/ !"0".*&+"! #,. )) +)4/&/ 3&0% a Mann-Whitney non 
parametric two-tailed test.  
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FIGURE LEGENDS 
 
Figure 1: Distribution of FALCs in VAT 
(a) Whole mount immunofluorescence staining of the mesenteries allowing visualisation of 
CD45+ FALCs (green) (b) Density of hematopoietic clusters (number of clusters/g adipose 
tissue) in the main fat deposits of the peritoneal (omental (n=8 mice), gonadal (n=7) and 
mesenteric (n=6) adipose tissues) and pleural cavities (mediastinal (n=13) and pericardial 
(n=8) adipose tissues) and in the subcutaneous fat (n=7). Data points and mean shown. 
Data pooled from two independent expts. (c) Percentages of clusters found in each fat 
deposit relative to the total number of clusters found in the peritoneal or pleural cavities. 
(d) Whole mount immunofluorescence staining showing a mesenteric FALC with CD11b+ 
myeloid cells (blue), CD45+ hematopoietic cells (green), IgM+ B cells (red), and CD4+ T 
cells (white). (e) Whole mount immunofluorescence staining showing a mesenteric FALC 
with CD45+ hematopoietic cells (green), CD31+ blood endothelial cells (red) and Lyve-1+ 
cells (blue). Scale bar 50 μm. (f) Enumeration of the mesenteric clusters of newborns and 
animals aged between 1 and 32 weeks (n=5, 5, 5, 5, 7, 18, 7, 7 mice per group). Data 
points and mean shown. 
 
Figure 2: CXCL13 expression by FALC stromal cells is necessary for B cell 
recruitment 
(a) Real-time PCR analysis of the indicated mRNA in LNs, mesenteric FALCs and 
adjacent fat (n=5, 4, 5). Mann-Whitney nonparametric two-tailed test between FALCs and 
fat Cxcl13 p=0.0159, Tnf p=0.0286, Ccl21 p=0.1143, Ltb p=0.0079, Ccl19 p=0.2857, Il7 
p=0.0286. (b-c) Numbers of mesenteric clusters in WT, Plt/plt, Ccr7-/-, and Cxcr5-/- mice 
(n=7, 6, 6, 6 mice per group), (b) and whole mount immunofluorescence staining showing 
FALCs with CD11b+ myeloid cells (blue), CD45+ hematopoietic cells (green), IgM+ B cells 
(red), and CD4+ T cells (white) (c) in the indicated mouse strains. (d) Whole mount 
immunofluorescence staining showing mesenteric FALCs in the indicated mouse strains 
with CD45+ hematopoietic cells (green), and CXCL13+ stromal cells (red). Scale bar 50 
μm. *p < 0.05, **p < 0.01, ***p< 0.001 and ****p <0.0001, ns not significant. 
 
Figure 3: B cell activation and differentiation in FALCs upon peritoneal immune 
challenge 
(a) NP-specific IgM and IgG ELISpot assays and number of AFC on isolated FALCs and 
spleen cells after NP-Ficoll IP immunisation of QMxB6 mice. Data correspond to PBS and 
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NP-Ficoll treated mice (n=12,12) pooled from 2 independent experiments (n=9 FALCs and 
12 spleen). Mann-Whitney nonparametric two-tailed test between PBS and NP-Ficoll 
immunised mice, FALCs IgM p=0.0037, spleen IgM p<0.0001, FALCs IgG p=0.0275 and 
spleen IgG p<0.0001. (b) Whole mount immunofluorescence staining of the mesenteries 
of Cg1-CrexQMmTmG mice that were immunised with either PBS (all cells red) or NP-
Ficoll that results in the generation of IgG1+-switched FALC B cells (green). (c-e) 
Peritoneal lavage cells from QM/QM EYFP+/- mice were transferred by intravenous (IV) 
injection into C57BL/6J mice 24 hours before immunisation with Alum-precipitated NP-
OVA. (d) Flow-cytometric analysis of cells isolated from the mesenteries, spleen and mLN 
of PBS and NP-OVA-immunised mice showing the percentage of EYFP+CD19+ NP-
specific B cells in live CD45+ gate (upper row) and percentage of CD38-GL7+ GC B cells in 
EYFP+CD19+ NP-specific B cells gate (lower row). (e) Quantification of the cell number of 
NP-specific B cells (left column) and NP-specific GC B cells (right column). Data 
correspond to PBS and NP-OVA treated mice (n=5, 6) pooled from 2 independent 
experiments. Mann-Whitney nonparametric two-tailed test between PBS and NP-OVA 
treated mice, percentages of NP+ B cells in the mesenteries p=0.0022, spleen p= 0.0455, 
mLN p= 0.0043, number of NP+ B cells in the mesenteries p= 0.0079, spleen p=0.0317, 
mLN p=0.0079, percentages of NP+ GC B cells in the mesenteries p= 0.0022, spleen 
p=0.0022, mLN p=0.0043 and number of NP+ GC B cells in the mesenteries p=0.0043, 
spleen p=0.0043, mLN p=0.0043. (f-h) C57BL/6J mice were immunised IP with Alum 
precipitated-PE. (g) Flow-cytometric analysis of the mesenteries of naïve and PE 
immunised mice showing percentages of PE+CD19+ B cells in live CD45+ gate (upper 
row), and CD38-GL7+ GC B cells in PE+CD19+ gate (lower row). (h) Quantification of the 
cell number of PE+ GC B cells. Data correspond to PBS and PE/Alum immunised mice 
(n=6, 7) pooled from 2 independent experiments. Mann-Whitney nonparametric two-tailed 
test between PBS and PE/Alum immunised mice, percentages of PE+ GC B cells in the 
mesenteries p=0.0043, spleen p= 0.0012, mLN p= 0.0012, number of PE+ GC B cells in 
the mesenteries p= 0.0043, spleen p=0.0012, mLN p=0.0012 (h). *p < 0.05, **p < 
0.01, ***p< 0.001 and ****p <0.0001.  
 
Figure 4: Factors controlling the development of FALCs 
(a) Number of mesenteric clusters in the indicated knockout mouse strains. Data 
correspond to WT, Ltβr-/-,  Ltα-/-, Rorc-/-, Rag2-/-, Rag2-/-γc-/-, germ free (GF), Tnfr1/2-/- and 
Tnf+/ ΔARE mice pooled from at least 2 independent experiments (n=19, 13, 8, 7, 10, 7, 9, 9, 
9 mice per group). Mann-Whitney nonparametric two-tailed test between WT and Rag2-/-
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γc-/- p< 0.0001, WT and GF p<0.0001, WT and Tnfr1/2-/- p=0.0002, WT and Tnf+/ ΔARE 
p<0.0001  (b) Whole mount immunofluorescence staining showing FALCs with CD11b+ 
myeloid cells (blue), CD45+ hematopoietic cells (green), IgM+ B cells (red), and CD4+ T 
cells (white) in the indicated mouse strains. (c-e) Microphotographs of the mesenteries (c), 
number of clusters (d) and whole mount immunofluorescence staining as in b (e) after 
PBS or Zymosan injection (n=8, 9).  Data pooled from 2 independent experiments. Mann-
Whitney nonparametric two-tailed test p<0.0001. Scale bar 50 μm. 
*p <0.05, **p <0.01, ***p<0.001****, p <0.0001. 
 
Figure 5: TNF is required for FALC formation upon inflammation 
(a) Number of clusters found in the mesenteries of Tnfr1/2-/- mice and whole mount 
immunofluorescence staining showing FALCs with CD11b+ myeloid cells (blue), CD45+ 
hematopoietic cells (green), IgM+ B cells (red), and CD4+ T cells (white) 72 hours after 
PBS or Zymosan injection. Data pooled from 2 independent experiments (n=6, 6). Mann-
Whitney nonparametric two-tailed test p=0.2424. (b) Number of clusters present in the 
mesenteries of WT and Tnfr1/2-/- mice reconstituted with WT bone marrow and whole 
mount immunofluorescence staining as in a after PBS or Zymosan injection. Data 
correspond to WT BM into WT mice (n=5, 5) and WT BM into Tnfr1/2-/- mice (n=6, 6) per 
group pooled from 2 independent experiments. Mann-Whitney nonparametric two-tailed 
test, WT BM into WT mice p=0.0079, and WT BM into Tnfr1/2-/- mice p=0.1688. (c) 
Enumeration of clusters in the mesenteries of the indicated mutant mouse strains and 
whole mount immunofluorescence as in a after PBS or Zymosan injection. Data 
correspond to WT mice (n=7, 7), T-Tnf-/- (n=6, 8), B-Tnf-/- (n=4, 6) and M-Tnf-/- (n=8, 13) 
mice in the control and treated group pooled from 2 independent experiments. Mann-
Whitney nonparametric two-tailed test WT p=0.0006, T-Tnf-/- p=0.0007, B-Tnf-/- p=0.0048 
and M-Tnf-/- p=0.2156. Scale bar 50 μm. (d) Flow-cytometric analysis showing TNF intra-
cellular staining 2 hours post Zymosan injection in mesenteric eosinophils (gated as 
CD45+CD11b+SSChighSiglec-F+), neutrophils (gated as CD45+CD11b+Siglec-F-Ly6-Ghigh), 
macrophages (gated as CD45+CD11b+Siglec-F-F4/80+) and monocytes (gated as 
CD45+CD11b+Siglec-F-F4/80-Ly6-chigh). Quantification of the percentages of TNF+ cells 
after Zymosan in myeloid subsets is shown in bar chart. Data correspond to WT mice in 
the control and treated group (n=8, 8) pooled from 2 independent experiments. Mann-
Whitney nonparametric two-tailed test, eosinophils p=0.1593, neutrophils p=0.3935, 
macrophages p=0.0002 and monocytes p=0.0002. The distribution of TNF+ myeloid cells 
in the different subsets is shown in the pie chart. **p <0.01, ***p<0.001. 
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Figure 6: CD1d restricted NKT cells are required for FALC formation 
(a-b) Number of mesenteric clusters in the indicated mouse strains (a) and whole mount 
immunofluorescence staining showing FALCs with CD11b+ myeloid cells (blue), CD45+ 
hematopoietic cells (green), IgM+ B cells (red), and CD4+ T cells (white) 72 hours after 
PBS or Zymosan injection (b). Data correspond to Rag2-/- (n=6, 6), µMT-/- (n=5, 5), 
CD3εtg26-/- (n=5, 5), TCRδ-/- (n=4, 6) and Cd1d-/- (n=5, 6) mice in the control and treated 
group pooled from 2 independent experiments. Mann-Whitney nonparametric two-tailed 
test, Rag2-/- p=0.5693, µMT-/- p=0.0025, CD3εtg26-/- p=0.7857, TCRδ-/- p=0.0095 and Cd1d-
/- p=0.5065. Scale bar 50 μm. **p <0.01, ns not significant. 
 
Figure 7: iNKT cell activation induces FALC formation 
(a) Flow cytometry of the mesenteries, spleen and mLN showing the percentage of CD3ε+ 
CD1d-αGalCer tetramer+ iNKT cells in the lymphocyte gate. Data are representative of 3 
independent experiments (b) Whole mount immunofluorescence staining showing CFSE 
loaded iNKT cells (green) in mesenteric FALCs with CD11b+ myeloid cells (blue) and IgM+ 
B cells (red) 24 hours after transfer. Data representative of 4 mice in 2 independent 
experiments. (c-d) Numbers of mesenteric clusters and whole mount immunofluorescence 
staining showing FALCs with CD11b+ myeloid cells (blue), CD45+ hematopoietic cells 
(green), IgM+ B cells (red), and CD4+ T cells (white) 72 hours after vehicle or αGalCer 
injection. Data correspond to WT mice in the control and treated group (n=6, 9) pooled 
from 2 independent experiments (c) and Tnfr1/2-/- mice in the control and treated group 
(n=9, 7) pooled from 3 independent experiments (d). Mann-Whitney nonparametric two-
tailed test, WT p=0.0004 and Tnfr1/2-/- p=0.2831. (e) Numbers of mesenteric clusters and 
whole mount immunofluorescence staining showing FALCs with CD11b+ myeloid cells 
(blue) and CD45+ hematopoietic cells (green) 72 hours after PBS or Zymosan injection in 
Rag2-/- mice (n=4, 5) and Rag2-/- mice transferred with high purity sorted CD3high T cells or 
CD3ε+ CD1d-αGalCer tetramer+ iNKT cells (n=6, 5). Data pooled from 4 independent 
experiments. Mann-Whitney nonparametric two-tailed test p=0.0043. (f) Numbers of 
mesenteric clusters in Jα18-/- mice and whole mount immunofluorescence as in c 72 hours 
after PBS or Zymosan injection (n=7, 6). Data correspond pooled from 2 independent 
experiments. Mann-Whitney nonparametric two-tailed test p=0.0012. Scale bar 50 μm. 
**p < 0.01, ***p< 0.001 and ns not significant. 
 
Figure 8: Formation of FALCs is dependant on IL-4Rα signaling 
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(a-b) Numbers of mesenteric clusters in the indicated mouse strains (a) and whole mount 
immunofluorescence staining showing FALCs with CD11b+ myeloid cells (blue), CD45+ 
hematopoietic cells (green), IgM+ B cells (red), and CD4+ T cells (white) 72 hours after 
PBS or Zymosan injection. Data correspond to WT (n=7, 6), Il4rα-/- (n=5, 5), Il4-/- (n=5, 6), 
and Il13-/- mice (n=4, 6) in the control and treated group pooled from 2 independent 
experiments. Mann-Whitney nonparametric two-tailed test, WT p=0.0012, Il4rα-/- p=0.8016, 
Il4-/- p=0.0043, and Il13-/- mice p=0.0095.  (c) Numbers of mesenteric clusters in Il13-/- mice 
and Il13-/- mice transferred with high purity sorted CD1d-αGalCer tetramer+ iNKT cells or 
CD3high T cells 72 hours after PBS or Zymosan injection. Data correspond to Il13-/- control 
(n=7), injected with Zymosan (n=6), injected with Zymosan and transferred with iNKT cells 
(n=6) and injected with Zymosan and transferred with CD3high T cells (n=6) pooled from 2 
independent experiments. Mann-Whitney nonparametric two-tailed test p=0.3625. Scale 
bar 50 μm. (d) Numbers of mesenteric clusters in C57Bl/6J and Il4ra-/- mice 72 hours after 
PBS or Zymosan injection. Data correspond to WT control (n=9) and treated (n=5) and 
Il4rα-/- control (n=7) and treated (n=5) pooled from 2 independent experiments. Mann-
Whitney nonparametric two-tailed test, WT p=0.001 and Il4rα-/- p=0.2159. (e) Scheme 
representing the cellular and molecular interactions involved in FALC formation during 
normal development (blue arrow) and following inflammation (red arrow). **p < 0.01, ***p< 
0.001 and ns not significant. 
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Supplementary Figure legends 
 
Supplementary Figure 1: FALC morphology 
Whole mount immunofluorescence staining showing a representative array of FALCs 
harvested from the mesenteries of a single mouse with CD11b+ myeloid cells (blue), 
CD45+ hematopoietic cells (green), IgM+ B cells (red), and CD4+ T cells (white). Scale bar 
50 μm.  
 
Supplementary Figure 2: B cell activation in FALCs upon peritoneal immune 
challenge 
 (a) Flow cytometry of the mesenteries of QM/QM (IgHNP/NP Igκ-/-) mice 24 hours post PBS 
(left panel) and NP-Ficoll (right panel) IP injection. In the CD45+ hematopoietic fraction, the 
different B cell subsets were identified according to the expression of CD19 and CD11b 
(first row), CD19 and CD5 (second row). The percentages of NP+Ki67+ cells in the B2 
(CD19+CD11b−CD5-), B1c (CD19+CD11b−CD5+), B1a (CD19+CD11b+CD5+) and B1b 
(CD19+CD11b+CD5-) cell subsets are shown (third and forth row). Image representative of 
2 independent experiments (n=6, 5). (b) Quantification of the percentage of NP+Ki67+ 
activated B cells in the mesenteries, PCL and spleen of QM/QM mice 24 hours after PBS 
or NP-Ficoll injections. Data are representative of 2 independent experiments (n=6, 5). 
Mann-Whitney nonparametric two-tailed test, B2 p=0.1905 and p=0.0079, B1c p=0.0159, 
p=0.0079, B1a p=0.0159, p=0.0079, B1b p=0.0159, p=0.0079. (c) Whole mount 
immunofluorescence staining showing FALCs from of QM/QM mice after PBS or NP-Ficoll 
injection with CD11b+ myeloid cells (blue), CD45+ hematopoietic cells (green) and IgM+ B 
cells (red). Scale bar 50 μm. *p < 0.05, **p < 0.01, ***p< 0.001, ****p < 0.0001, and ns not 
significant. 
 
Supplementary Figure 3: ILC2 in VAT and FALCs 
(a) Flow cytometry of the mesenteries showing CD45+Lin-c-kit+Sca-1+IL-7Rα+ ILC2 in WT 
(first row) and Rag2-/- (second row) mice (NK1.1 and CD4 present in Lin cocktail). (b) Flow 
cytometric analysis of the mesenteries showing CD45+Lin-Sca-1+NK1.1- ILC2 and 
CD45+Lin-Sca-1-+NK1.1+ NK cells in Rag2-/- mice.  (c) Whole mount immunofluorescence 
staining showing FALCs in Rag2-/- with CD11b+ myeloid cells (blue) and CD90+ ILC 
(green). Scale bar 50 μm.  
 
Supplementary Figure 4: Myeloid cells are recruited to FALCs upon inflammation 
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(a) Whole mount immunofluorescence staining showing FALCs containing CD11b+ 
myeloid cells (blue) and Ly6C+ monocytes (first row, green), Gr1+ granulocytes (second 
row, green) or F4/80+ macrophages (third row, green) after Zymosan injection. Scale bar 
50 μm. 
 
Supplementary Figure 5: IFN-γ  is not necessary for FALC formation upon 
inflammation 
Number of clusters found in the mesenteries of Ifnγ-/- mice and whole mount 
immunofluorescence staining showing FALCs with CD11b+ myeloid cells (blue), CD45+ 
hematopoietic cells (green), IgM+ B cells (red), and CD4+ T cells (white) 72 hours after IP 
injection of PBS or Zymosan. Data corrrespond to control (n=6) and treated (n=4) mice 
pooled from 2 independent experiments. Mann-Whitney nonparametric two-tailed test, 
p=0.0095.  Scale bar 50 μm. **p < 0.01. 
 
Supplementary Figure 6: IL-4c induces a partial rescue of inflamation-induced FALC 
formation in the absence of TNF signalling   
(a) Number of clusters found in the mesenteries of C57BL/6J mice and whole mount 
immunofluorescence staining showing FALCs with CD11b+ myeloid cells (blue), CD45+ 
hematopoietic cells (green), IgM+ B cells (red), and CD4+ T cells (white) 4 days after PBS, 
TNF, IL-4c and both TNF and IL4c injections. Data correspond to control (n=6) and TNF 
(n=6), IL-4c (n=7) and TNF+IL-4c (n=7) treated mice, pooled from 2 independent 
experiments. Mann-Whitney nonparametric two-tailed test, PBS and TNF p=0.4248, PBS 
and IL-4c p=0.4156, PBS and TNF+IL-4c p= 0.7964. (b) Number of clusters found in the 
mesenteries of C57BL/6J, Il4rα-/- and Tnfr1/2-/- mice and whole mount 
immunofluorescence staining as in a, 4 days after PBS, Zymosan, Zymosan+TNF, and 
Zymosan+IL-4c injections. Data correspond to PBS (n=13), Zymosan (n=15) and 
Zymosan+TNF (n=9) treated WT mice pooled from 3 independent experiments, and to 
PBS (n=7), Zymosan (n=7) and Zymosan+TNF (n=8) treated Il4rα-/- mice pooled from 2 
independent experiments, and to Zymosan (n=7) and Zymosan+IL-4c (n=7) treated 
Tnfr1/2-/- mice pooled from 2 independent experiments. Mann-Whitney nonparametric two-
tailed test WT PBS and Zymosan p<0.0001, WT PBS and Zymosan+TNF p=0.0052, Il4rα-
/- PBS and Zymosan p=0.0105, Il4rα-/- PBS and Zymosan+TNF p=0.0365, Il4rα-/- Zymosan 
and Zymosan+TNF p=0.7574, and Tnfr1/2-/-  Zymosan and Zymosan+IL-4c p=0.0029. 
Scale bar 50 μm.  *p < 0.05, **p < 0.01, ***p< 0.001 and ****p <0.0001, ns not significant. 
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